The aim of this study is to investigate the applicability of poly(lactic-co-glycolic acid) (PLGA)/collagen composite scaffold for skin tissue engineering. PLGA and collagen were dissolved in HFIP as a common solvent and fibrous scaffolds were prepared by electrospinning method. The scaffolds were characterized by scanning electron microscopy (SEM), FTIR spectroscopy, mercury porosimetry, tensile strength, biocompatibility assays and Biodegradation. Cytotoxicity and cell adhesion were tested for two cell line groups, human dermal fibroblast (HDF) and human keratinocyte (HaCat). SEM images showed appropriate cell adhesion to the scaffold for both cell lines. MTT assays indicated that the cell viability of HDF cells increased with time, but the number of HaCat cells decreased after 14 days. The ultimate tensile strength was suitable for skin substitute application, but its elongation at break was rather low. For successful clinical application of the PLGA/collagen scaffold, some properties especially mechanical strain needs to be improved.
Chitosan due to outstanding properties including biocompatibility, biodegradability, nontoxicity and antibacterial activity has received considerable attention in different fields of biomedical engineering.To study the effect of morphology and topology on antibacterial activity of chitosan, two samples of PVA/Chitosan blend with the same concentration and volume ratio were prepared using electrospinning and film casting methods. To improve the electrospinability of chitosan, it was hydrolyzed by 50% V NaOH solution (95°C for 48 h.) and PVA was used as an auxiliary polymer for electrospinning. The best electrospinning parameters for producing beadless structure were determined at a voltage of 21 kV and distance of 15 cm. Different physical and chemical characterizations of produced samples were performed using scanning electron microscopy (SEM), Fourier Transform Infrared Spectroscopy (FTIR), viscosimetry, Atomic Force Microscopy (AFM) and antibacterial assay by two different bacterium strains including Escherichia coli (E.coli) as the gramnegative and Staphylococcus aureus (S.aureus) as the gram-positive bacteria. Antibacterial assays revealed higher sensitivity of E.coli in comparison with S.aureus in the two samples. Also, it revealed that nanotopography of surface wielded influence on the antibacterial activity of samples.
Bioactive glasses have shown some interesting biological properties such as biocompatibility, biodegradation, and angiogenesis in skin tissue engineering. In the current research, the effects of MgO- or CoO-doped 64S bioactive glass with a composition of 64 SiO2-26 CaO-5 P2O5-5 MgO or CoO (mol%) were studied in relation with biological properties of electrospun [poly(lactic-co-glycolic acid) (PLGA)/collagen]. PLGA/collagen samples were rinsed in suspension of bioactive glass nanoparticles in distilled water with a concentration of 0.1 w/v and then freeze dried. Cell adhesion, viability, angiogenesis, and ionic release were performed and tested in culture medium containing fibroblast cells. Attachment and viability of fibroblast cells were increased significantly in bioglass-coated samples, while shrinkage in PLGA/collagen scaffold was reduced by the addition of bioactive glass. Vascular endothelial growth factor secretion in coated scaffold was dropped compared to the uncoated samples. This could be attributed to the fast degradation of glass nanoparticles, according to the inductively coupled plasma-atomic emission spectroscopy results.Electronic supplementary materialThe online version of this article (10.1007/s40204-018-0089-y) contains supplementary material, which is available to authorized users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.